How Much Do Peptides Cost to Make? What to Verify

How much do peptides cost to make?

There is no universal unit price for making peptides. An industrial review separates manufacturing cost into staff, pilot plant time, and raw materials, with contributions varying by scale and peptide length. For a business plan, request a written specification and matching supplier quote instead of assuming a production figure. [1]

A public synthesis price tells you what one vendor offers under its stated conditions. It does not disclose that vendor's internal production expense or the full amount your store would spend to acquire, review, package, and hold an acceptable lot. Bio Basic, for example, directs customers to inquire about longer peptides or larger scales instead of extending its posted table to every project. [3]

Your first question should be, "What would this supplier deliver for this specification, and what would remain our responsibility?" The comparison tools below attach each answer to a document. Use them to manage a purchasing decision, not to calculate a universal manufacturing cost.

Key Facts

• An industrial review divides peptide manufacturing cost into staff, pilot plant time, and raw materials. [1]
• The same review says each category's contribution changes with project scale and peptide length. [1]
• Solvents are described as a major raw material cost driver for solid phase peptide synthesis; that finding does not supply a retail unit price. [1]
• Purification of crude peptide can involve chromatography and substantial solvent use, so a synthesis label alone does not establish the full processing scope. [1]
• Bio Basic asks customers to inquire about longer peptides and larger scales rather than treating its posted table as a complete custom quote. [3]
• ICH Q7 describes certificates for batches of intermediates or active pharmaceutical ingredients in its scope; its wording does not automatically govern every research material. [2]

TL;DR

There is no defensible universal amount to put into a peptide store plan as "cost to make." Define the requested material and acceptance evidence, obtain written quotes against the same scope, and leave unquoted expenses blank. Treat manufacturing cost, a supplier's selling price, and your own landed inventory cost as separate figures.

What goes into the cost of making peptides

The answer for a specific peptide is a scoped manufacturer estimate or actual internal production record, not a price inferred from a public table. An industrial review names staff, pilot plant time, and raw materials as manufacturing cost categories, and says their relative contribution varies with scale and peptide length. [1]

Which "cost" are you trying to know?

Write the question at the top of your worksheet before entering any amount. Manufacturer process cost is what the producer expends to run a defined project. Supplier selling price is what the supplier asks your business to pay under an offer. Landed inventory cost is your business's documented acquisition cost after the charges and work needed to receive inventory have been identified. The last two are potentially visible to you; the first may remain undisclosed. A quote is evidence of an offer, not an audit of the producer's accounts.

This distinction matters even when the same company makes and sells the material. Its quote might include testing or packaging, or it might assign those items to a separate order. The published industrial model does not say how any individual vendor allocates overhead, sets a margin, or bundles services. [1] Your spreadsheet should therefore label its input "quoted supplier charge" rather than "manufacturing cost" unless you actually have evidence for the latter.

The word unit also needs a definition. A price per sequence, per ordered batch, per mass of delivered material, and per packaged store item answer different questions. None becomes comparable by deleting the unit label. Record both the unit in which the supplier quotes and the unit you need for your own plan. If a conversion depends on quantities that have not been confirmed, keep the conversion pending. Do not turn a preliminary inquiry into a precise inventory cost by assuming a yield or an eventual pack count.

What does the industrial cost tree explain?

The cost tree starts with the review's three categories: personnel, pilot plant time, and raw materials. The authors explicitly say their relative weight changes by project, including with scale and peptide length. They also identify solvents as a major raw material driver for solid phase synthesis. [1] You can use these categories to ask where a change in scope might create extra work. The categories are not line items you can independently price without the producer's project information.

The fourth row is an editorial question, not a fourth cost category attributed to the review. The review discusses purification and isolation as meaningful industrial operations, including chromatography and solvent use. [1] The question protects you from reading "synthesis" as a promise that every downstream activity has been priced. You do not need a manufacturer's confidential bill of materials to ask what the contract includes.

How do you test whether two price statements can be compared?

Start with a comparability test, not arithmetic. Put the source of each price beside the exact item or requested target, quantity and unit, purity or other acceptance specification, analytical package, documentation, packaging, delivery boundary, and quote date. If either statement lacks a field that could change your decision, request clarification. A blank field is not a zero charge. A supplier may later include the item, charge separately, decline it, or offer an alternative.

For a hypothetical example, imagine that Supplier A supplies a table price for a listed quantity while Supplier B sends a custom quote for a different requested quantity and a documented analytical package. Calling A cheaper would compare two different transactions. The next move is to send both suppliers the same request and ask them to identify every exception. No dollar estimate is needed to reach that decision. Bio Basic's own page shows why a posted table has a boundary: it asks for inquiry on longer peptides or larger scales. [3]

What should happen when the request changes?

Version the request. If your team changes the target, requested quantity, acceptance criteria, document package, or delivery arrangement, send a revised specification to each supplier. Retain the earlier version to explain why an older figure appears in planning notes. The published industrial review establishes that scale and length can change the cost mix, and a vendor's page can have explicit custom inquiry boundaries. [1] [3] That is enough reason to seek a fresh answer rather than silently carrying forward a figure.

For a hypothetical example, suppose a founder first asks for a crude research material and later asks for purified material with a different evidence package. The second request is a different offer even if the peptide name is unchanged. The comparison sheet should preserve both specifications, mark the first price as inapplicable to the new request, and wait for a revised quote. It should not "adjust" the earlier price with an invented percentage.

How much does it cost to synthesize peptides?

A synthesis price depends on the requested project and on what the seller includes; the source record does not support a universal amount. The industrial review describes variable scale and length effects, substantial solvent use, and downstream purification work. A vendor table provides a bounded offer, while a custom request can specify the scope your business actually needs. [1] [3]

What does "synthesis" cover in a commercial request?

The industrial review describes solid phase peptide synthesis as a widely used chemical method that can be automated and scaled. At a business level, the process is more than a single material purchase: building the target, separating material, and, where specified, purifying and isolating it are distinct scopes of work. The review notes that crude peptide purification commonly uses chromatography and can consume significant solvent. [1] You do not need an operating protocol to see why a quote that names only synthesis may not answer every downstream question.

Put a simple scope line in your request: material identity and specification; requested quantity; included processing; analytical evidence; delivered form; packaging; delivery boundary; and exceptions. This is an editorial purchasing template. It does not assert that every supplier uses the same process or that every project requires the same test. The supplier should describe the work it has actually offered, and your qualified reviewer should assess whether that work meets your intended business need.

Which specification fields belong in an RFQ?

An RFQ is a request for quotation. The worksheet below is a field dictionary for a commercial conversation, not a technical manufacturing instruction. Each field states what you want compared, who should supply the answer, and what would make the answer usable. You can leave a field open while you determine whether it applies; do not fill it with a guess to make the form look complete.

Why do scale and length change the conversation?

The industrial review says the contribution of personnel, pilot plant time, and raw materials varies with project scale and peptide length. [1] That is a statement about variability, not a formula that predicts a price change. A public vendor page offers a second, narrower observation: Bio Basic explicitly asks customers to inquire about longer peptides or larger scales. [3] Neither source supports a universal charge per amino acid or a transferable multiplier for a store plan.

Suppose, in a hypothetical example, a founder has a table entry for one scale but wants a larger order. The sound move is to ask for a new written quote at the desired quantity, with the same acceptance specification. It would be unsound to multiply the table entry by the quantity ratio and present the result as the supplier's offer. The supplier may change its process, schedule, documentation, or commercial terms; the available sources do not let you predict which.

What is the difference between a table and a tailored quote?

A table can show the boundaries of one seller's published offer. Bio Basic directs customers to inquire about longer peptides or larger scales. [3] That is evidence about that page's inquiry boundary. It is not a disclosure of Bio Basic's internal manufacturing cost, a market average, or an endorsement of that supplier.

Ask specifically whether the quote includes purification, isolation, requested testing, a certificate package, packaging, and shipment to the agreed destination. These are separate questions because the industrial review describes downstream steps as substantive work, while the vendor pages demonstrate that public price descriptions can be bounded. [1] [3] The answers belong in writing, attached to the same RFQ version.

Can you turn a synthesis quote into a store unit cost immediately?

Only if every relevant unit and scope has been established, and even then call the result your own documented calculation, not the manufacturer's process cost. A synthesis offer can be one acquisition input. Your business may also need to account for work and charges it actually incurs after the quoted delivery point. List those categories as blank rows until invoices, signed terms, or qualified estimates exist. Do not borrow a supplier's public unit price to fill unrelated cost cells.

For a hypothetical example, imagine an offer for a stated bulk quantity that includes an analytical package but ends before your chosen delivery point. A second offer reaches your delivery point but does not yet state its analytical deliverables. The first has an open logistics row; the second has an open evidence row. No fair total can be calculated by pretending both open rows are zero. Your worksheet should identify which question each supplier must answer next.

The supplier sourcing guide can help frame additional sourcing questions, while the RFQ remains the controlling document for this comparison. Do not infer import terms, carrier obligations, or a legal classification from a manufacturing quote. Those questions need the applicable current rules and transaction documents.

Is it hard to manufacture peptides?

Industrial manufacture can be operationally demanding, but you cannot assign one difficulty level to all peptide projects. The cited review says large scale activities such as adding materials, filtering, isolation, and purification take time and present engineering challenges; it also notes that changing an API solvent system can alter purity attributes. [1]

Why is a laboratory description insufficient for a commercial decision?

The review explains that solid phase synthesis can be automated and scaled, then describes why industrial scale adds practical constraints. It specifically identifies time spent on heating, filtering, material addition, isolation, and purification. [1] That contrast is useful to you because a short description of the chemistry does not tell you whether a supplier can deliver your requested scale, specification, and documents under a particular quote.

What should a feasibility interview cover?

Keep the interview commercial and evidence focused. Ask whether the supplier has reviewed the exact version of the target specification, what it can commit to deliver, what conditions could cause a revised offer, what analytical evidence will accompany a lot, and who will answer technical exceptions. These prompts organize a purchasing decision. They are not a synthesis procedure, and you should not reinterpret them as instructions for a manufacturer.

Why do downstream steps matter to feasibility?

The industrial review says crude peptide can undergo several purification steps, commonly with chromatography, and that purification can consume significant solvent. It also describes isolation as its own stage. [1] This supports a practical scope question: does a supplier's stated output mean crude material, material purified to a specified target, or a different deliverable? Do not assume any one of those is included because the page says "custom synthesis."

Your review log should have separate rows for the requested final specification, the work the supplier says it will perform, and the evidence it will send. If a quote gives a purity category but no method, ask how that category is defined in the offer. If it promises a certificate but no sample or field list, ask what the certificate will identify. These are commercial document questions, not claims that one method is always right.

What changes when a process changes?

The review warns that a seemingly simple solvent system change can affect the purity profile and critical quality attributes associated with an active pharmaceutical ingredient. [1] That is an API context. It does not establish that every research material is an API or that the same regulatory work applies to every research seller. It does support a narrower business lesson: a revised process may require the supplier and an appropriate reviewer to revisit what the earlier evidence and quote still cover.

For a hypothetical API project, suppose the manufacturer proposes a different solvent system after your quote comparison was approved. Ask which specification, analytical method, evidence package, and quotation terms would change, and ask the responsible qualified team to assess the effect. Do not merely change the word "solvent" in a spreadsheet and keep the old acceptance decision. The industrial review supplies the reason to reopen the API purity question; it does not supply your project's answer. [1]

For a hypothetical research material whose classification has not been established, the same business record can still capture the proposed change and request an updated supplier explanation. Do not import API rules by analogy. Mark the applicability question unresolved and seek qualified review of the actual material and intended activity. If the new proposal changes what you would receive, ask for a revised quote before making a purchasing choice.

How do you keep feasibility separate from permission to sell?

A supplier's willingness to make or quote a material does not decide whether your planned U.S. business activity is permitted. This article's manufacturing sources do not classify your product or approve its marketing, distribution, or claims. Keep a separate review of the actual product, intended use, site content, and applicable rules. The research use only guide and the legality guide explain questions to put to qualified counsel; neither replaces advice for your specific facts.

This separation prevents a subtle spreadsheet error. A team might label a quote "approved" because the price and analytical package look coherent, then read that label as approval to list the product. Use narrower statuses: quote comparable, technical evidence under review, contract ready, and business classification unresolved. An accepted commercial offer answers only the matters its review actually covered. Keep each decision owner and date next to the status.

Supplier records to request

Ask for records that connect the agreed specification, the supplier's offer, and the material actually delivered. The exact document set depends on the product and transaction. ICH Q7 provides detailed examples for intermediates and active pharmaceutical ingredients within its scope, while one custom synthesis vendor describes its own analytical package; neither source establishes a universal requirement for every research material. [2] [4]

Which records answer different questions?

Keep three questions separate. What was requested? Save the dated RFQ, its specification version, the supplier's acknowledgement, and any written exception. What was offered? Save the quote with its quantity, included services, document package, delivery terms, validity period, and conditions. What arrived? Match the received item's identifier and lot reference to the supplier's delivery record and the analytical documents that accompanied it. This is an editorial record design for you. It is not a claim that a particular file name or test is required for every product.

A quote cannot stand in for evidence about a delivered lot. It may promise testing, but it does not itself show the result of that testing. Likewise, a certificate title alone does not explain which material was examined or which criterion a result addresses. Put the promised document name in one column and the received document name in another. If the latter remains blank, the delivery review remains open even though the commercial order is complete. The guide to choosing a peptide testing lab gives a separate place to consider who can evaluate the analytical question.

The final row is your business record, not something a supplier can issue on your behalf. It prevents a common handoff problem: a buyer saves a certificate and someone later assumes that its presence means a qualified person accepted its contents. Record whether the review addressed identity, a particular analytical result, a contract term, or only document completeness. A decision that covers one topic should not be reused as approval for all the others.

When is ICH Q7 relevant to the document request?

ICH Q7 is a guide for good manufacturing practice for active pharmaceutical ingredients. Its certificate section says authentic certificates of analysis should be issued for each batch of intermediate or API on request. For an API certificate, it calls for listed tests, acceptance limits, and numerical results when results are numerical. [2] These are concrete API context examples. Whether your item and activity fall within that context requires a separate classification and qualified review; the word peptide alone does not answer it.

The distinction matters because you can make opposite errors with the same PDF. One error is to say that any certificate bearing a purity figure satisfies Q7. Another is to tell a research seller that Q7's API provisions automatically control every order. The source supports neither shortcut. In its API context, Q7 also discusses purchasing materials against an agreed specification from suppliers approved by the quality unit. [2] That statement concerns an API manufacturer's materials management; it should not be recast as a blanket rule for every storefront buying finished research material.

For a hypothetical API project, suppose a certificate reports a numerical result but leaves out the relevant acceptance limit. The Q7 example gives the qualified quality team a specific gap to raise: which limit applied and where is it recorded? [2] For a hypothetical research material whose classification is unresolved, a similar missing field may still be a useful purchasing question, but do not label it a Q7 violation on these facts. Ask what was contractually promised and what standard the supplier claims to have followed.

What can a vendor's advertised document bundle establish?

Biomatik states that its custom peptides come with a certificate of analysis, mass spectra, and HPLC chromatograms. [4] That is a statement about Biomatik's advertised service, not evidence that every supplier includes those documents or that any particular delivered lot meets your specification. The practical use of the page is to reveal how much detail a document promise can contain. Ask each candidate supplier to state its own deliverables in its quote. Do not treat the named vendor as a recommendation or transplant its advertised bundle into another supplier's contract.

For a hypothetical comparison, Supplier A states that those three documents accompany its offer, while Supplier B writes only "certificate included." Both offers may be commercially interesting, but the document scopes are not yet aligned. Ask B whether analytical traces and method descriptions are included, ask A which lot identifier will appear on the files, and compare the written answers. If B says the additional files are unavailable, that is a substantive difference for a reviewer to evaluate. A lower price cannot erase it; an elaborate document list cannot prove that its results are acceptable without review.

Separate sample document from delivered document. A sample can show the fields and format a vendor intends to supply. It cannot establish that the material you later receive passed a stated limit. When the actual lot arrives, link its identifier to the actual analytical file and record the review outcome. If an exception or corrected file arrives, retain the earlier version and explain the replacement. This simple lineage makes the quote comparison usable after purchasing, when memory of a sales conversation is no longer enough.

How should you manage missing or conflicting records?

Open one question per gap. Write the exact field at issue, the source document, the person responsible for answering, the requested response, and the date of the next decision. A document that names one target while the order names another requires reconciliation, not a guess about synonyms. A supplier response that changes the specification should create a revised request and perhaps a revised quote. A missing method reference should go to the reviewer who knows whether that method is material to your acceptance question.

Use the supplier vetting checklist for broader supplier due diligence, but keep this lot's documentation log attached to this order. A supplier can be worth considering while a particular lot remains unresolved. Conversely, one complete file set does not answer every future question about the supplier. The record should end with a narrow disposition: information requested, documentation received, technical review pending, quote revised, or decision recorded. Do not use a single check mark to cover all of those states.

Comparing supplier quotes

Compare written offers against one versioned request, with the same target, quantity, acceptance specification, document package, and delivery boundary. If a material field is missing, the comparison is pending. Normalize the scope first, then compare charges that actually answer the same purchasing question. A published table or a certificate promise cannot fill a blank in another supplier's offer. [3] [4]

What belongs in the side by side worksheet?

Keep the suppliers' original words in separate source columns. Add a normalized column only for your interpretation and a decision column for unresolved differences. This prevents an editor from silently converting "available on request" into "included" or a public table entry into a custom quote. The worksheet below deliberately leaves all prices blank. Enter a supplier amount only after you can attach the dated response and its unit.

The cells are prompts, not claims about what any real supplier will include. Add a link or file reference to every answer. If you have only an oral statement, request written confirmation before treating it as a contractual inclusion. A quote may be conditional on a technical review or later specification; copy that condition into the same row as the price. The decision field should say aligned, difference accepted after review, or unresolved. It should not hide a difference by forcing both offers into an artificial common label.

How do you normalize two incomplete offers?

For a hypothetical example, both suppliers receive the same versioned RFQ for the same target and requested quantity. Supplier A responds with a lower headline charge but leaves purification and analytical deliverables unspecified. Supplier B states that purification is included and lists its analytical files, but its delivery boundary stops before the founder's receiving location. No numerical price is needed for the conclusion: neither quote yet supplies a comparable complete cost at the founder's desired boundary. The next action is a written clarification to A about processing and documents and to B about delivery responsibility.

In this hypothetical walkthrough, A's returned specification also names a target purity different from the RFQ. Record the mismatch and request a corrected specification before treating the offers as comparable. Keep the missing analytical package in its own unresolved cell; a revised commercial amount would not answer that question.

Record an explicit Q7 applicability decision for this same hypothetical comparison: unresolved, qualified classification required. If the actual project is confirmed to be an intermediate or API within relevant scope, ask the responsible quality team to compare both offered document packages with the applicable Q7 provisions. [2] If that scope is not established for the contracted research material, record the governing agreed standards and records without claiming that Q7 automatically applies. The hypothetical founder's current decision is HOLD until classification, specification mismatch and missing deliverables are resolved. A classification determination or corrected supplier response triggers a dated revision of the comparison.

Suppose, in that hypothetical example, A later confirms that purification is excluded and offers a separate charge. Keep A's original quote intact, add the new response with its date, and calculate a total only if the additional work meets the same specification and delivery boundary as B. If B later adds delivery terms, attach those too. Your comparison becomes valid only for the fields that are then aligned. A revised quote may still leave a technical acceptance issue open, so a commercially comparable total is not automatically an acceptable purchase.

Here is the sequence to record for each offer: request version → supplier response → exception list → clarification → revised offer → technical review → commercial decision. The arrows describe a management record, not a manufacturing process. Do not erase an intermediate answer when a later one changes it. The history explains why an initial amount was rejected or superseded. It also helps a colleague see which supplier must answer the next question without repeating the whole discussion.

What decision can the worksheet support without a dollar estimate?

The worksheet can support a hold decision, a request for clarification, or a decision to obtain qualified review. Those are real outcomes. If the request version differs, send the same current version to both suppliers. If the offered target differs, stop the price comparison until the difference is resolved. If the scope aligns but the analytical evidence differs, ask the reviewer whether the difference matters to the specified acceptance criteria. If only delivery terms differ, request a written boundary and put each downstream responsibility in its own row.

Do not rank suppliers by how many cells contain text. An answer can be detailed and still fail to address the requested specification. Nor should you average two quotes to create a planning figure while their scope differs. An average of unlike offers has a precise appearance and an unclear meaning. Keep any internal planning assumption separate, visibly provisional, and tied to the decision it informs. No source here establishes a market average, a universal markup, or a standard gross margin. The pricing guide addresses the later selling price model after acquisition inputs are grounded.

For a hypothetical example, a founder wants to budget before a supplier will commit to a date. The useful note is, "Quote pending for the current RFQ; no supplier charge entered; schedule assumption unresolved." That note allows the founder to identify a gap without pretending to know the answer. If the founder later obtains a dated offer, the record can move from unverified to quoted. After a transaction, the invoice and actual other charges can be recorded under their own labels. This preserves the difference between a forecast and an observed expense.

When should a comparison be reopened?

Reopen it when the target or specification changes, the requested scale changes, an analytical or certificate package changes, a supplier adds an exclusion, a delivery boundary changes, or a quote reaches its stated validity limit. Also reopen it if the received evidence no longer matches the offer on which your selection relied. The industrial review gives a reason to take changes seriously: scale and length influence the cost mix, and a process change can affect API purity attributes. [1] It does not predict the direction or size of your particular quote change.

The practical closeout is a one page decision note. Name the RFQ version, list the responses reviewed, identify every accepted difference, show the remaining blank cost or evidence cells, and name the person who can close each one. Record the decision as select, seek revised offer, or hold, with the scope of any technical and business review made explicit. A quote can be selected for a next conversation while purchase and product classification remain unresolved. That precision is more useful than a declaration that one supplier is simply cheapest.

What to do next

1. Write at the top of your worksheet which cost you want to know: manufacturer process cost, supplier selling price, or landed inventory cost.

2. Define your request in a versioned RFQ that names the target, quantity and unit, acceptance specification, analytical package, documentation, packaging, and delivery boundary.

3. Send the same current RFQ version to each supplier and ask each to identify every exception in writing.

4. Save the record of what was requested, what was offered, and what arrived, and leave every unquoted or unconfirmed cell blank.

5. Compare the written offers side by side in one worksheet, normalize the scope first, and enter a price only after the scope aligns.

6. Record one decision for each comparison: select, seek revised offer, or hold.

7. Reopen the comparison whenever the target, scale, document package, delivery boundary, or quote validity changes.

When should you book a peptide business fit call?

Book a fit call when you have a written RFQ, supplier responses, and a worksheet showing which documentation or cost assumptions remain open. Bring the versioned comparison so the discussion can focus on your business model and the questions to send back to suppliers. The call does not replace a supplier quote, qualified technical review, or advice about your specific legal position.

Frequently Asked Questions

Can a vendor price prove manufacturing cost?

No. A vendor price is an offer to a buyer, while the industrial review describes the producer's staff, pilot plant time, and raw material categories. [1] Unless the producer supplies project records that establish its own expense, label the number a quoted supplier charge rather than manufacturing cost.

Should you use a universal markup?

No universal markup follows from the sources in this article. Build your own pricing model from documented acquisition and operating inputs, and label unverified assumptions clearly. The pricing guide is a separate place to work through that decision without turning a supplier quote into a promise of profit.

What quality controls matter?

The answer depends on the material, agreed specification, and applicable framework. For an API within relevant scope, ICH Q7 discusses certificates on request for each batch and lists tests, acceptance limits, and numerical results where applicable. [2] For another material, ask a qualified reviewer which records answer the specific acceptance question rather than assuming the API example applies automatically.

When should a quote be refreshed?

Request a fresh written response when the target, quantity, acceptance criteria, document package, or delivery terms change, or when the quote's own validity period ends. Preserve the old version so the change remains traceable. Bio Basic's explicit inquiry boundary for longer or larger work illustrates why a public entry should not be stretched beyond its stated scope. [3]

Sources

1. Royal Society of Chemistry, "Greening the synthesis of peptide therapeutics: an industrial perspective,", accessed 2026-09-29.

2. International Council for Harmonisation, "Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients,", accessed 2026-09-29.

3. Bio Basic, "Pricing | Peptide Synthesis," https://www.biobasic.com/peptides-pricing/, accessed 2026-09-29.

4. Biomatik, "Peptide Synthesis," https://www.biomatik.com/services/peptide-synthesis.html, accessed 2026-09-29.

Educational and legal disclaimer

This article provides educational information only. It is not legal, regulatory, tax, medical, product, import, platform, or payment advice. It makes no claim about personal use or health outcomes. Ask qualified professionals to evaluate the rules, specifications, and documentation that apply to your actual product and transaction before acting.